Therefore, the aim is to find the usefulness of the MRD “lite” panel for post-induction MRD detection in pediatric B-ALL using CD38, CD10, CD34, CD19, and CD45 compared to the “standard tube” panel. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.